Metabolix, Inc. Stock Nasdaq
Equities
US5910188094
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 2.25M | Sales 2025 * | 4M | Capitalization | 3.6M |
---|---|---|---|---|---|
Net income 2024 * | -11M | Net income 2025 * | -13M | EV / Sales 2024 * | 1.6 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.9 x |
P/E ratio 2024 * |
-0.31
x | P/E ratio 2025 * |
-0.27
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0% |
Latest transcript on Metabolix, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Oliver Peoples
FOU | Founder | 66 | 92-05-31 |
Charles Haaser
DFI | Director of Finance/CFO | 68 | 07-12-31 |
Kristi Snell
CTO | Chief Tech/Sci/R&D Officer | 56 | 96-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 67 | 06-09-30 | |
Richard Hamilton
BRD | Director/Board Member | 61 | 17-03-01 |
Oliver Peoples
FOU | Founder | 66 | 92-05-31 |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |